SCHEMBL29947057

SCHEMBL29947057

Cc1ncnc2ccc(-c3cnc(N)nc3-c3ccc(F)cc3)cc12

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 12/20 0.55
▸ RPS6KA3 P51812 1/20 0.49
▸ MAP4K4 O95819 3/20 0.48
▸ ADORA2A P29274 7/20 0.45
▸ EGFR P00533 1/20 0.45
▸ KMT2A Q03164 1/20 0.44
▸ TGFBR1 P36897 1/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ MTOR P42345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621288 1.00 ADORA1 (0.55) ADORA1RPS6KA3MAP4K4ADORA2AEGFR
SCHEMBL28345882 0.89 ADORA1 (0.61) ADORA1MAP4K4ADORA2AKMT2ATGFBR1
SCHEMBL29947093 0.89 ADORA1 (0.61) ADORA1MAP4K4ADORA2AKMT2ATGFBR1
SCHEMBL23965690 0.88 ADORA1 (0.47) ADORA1RPS6KA3MAP4K4ADORA2AKMT2A
SCHEMBL30721834 0.84 MAP4K4 (0.49) MAP4K4EGFRTGFBR1PIK3CDPIK3CA
SCHEMBL22172329 0.84 MAP4K4 (0.49) MAP4K4EGFRTGFBR1PIK3CDPIK3CA
SCHEMBL30353569 0.84 ADORA1 (0.53) ADORA1RPS6KA3ADORA2AKMT2A
SCHEMBL28342675 0.84 ADORA1 (0.53) ADORA1RPS6KA3ADORA2AKMT2A
SCHEMBL22180298 0.83 MAP4K4 (0.51) MAP4K4EGFRTGFBR1
SCHEMBL24119096 0.83 ADORA1 (0.55) ADORA1RPS6KA3ADORA2AKMT2APIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 — — CN disclosed
CN-110684020-B 2-aminopyrimidine derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-01-20 — — CN disclosed
CN-111094254-B Heteroaryl derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2022-07-26 — — CN disclosed
Send feedback